USC News

Menu Sunday, April 5, 2020 58° Partly Cloudy

Health

Search
Health
cardiovascular drugs reduce dementia risk
Though there are no drugs that can treat Alzheimer’s disease and related dementias, even small delays in onset that have been linked to statins and other blood pressure medicines can dramatically reduce the burden dementia on patients, caregivers and the health system as a whole. (Photo/iStock)

Certain combinations of cardiovascular drugs may reduce dementia risk

In a first, a USC study has shown that drugs already being used for blood pressure and cholesterol control could provide benefits for Alzheimer’s and other dementias.

Health
neuroimaging schizophrenia
Researchers used a series of advanced techniques developed at the USC INI to measure and map the shape and volume of various brain structures. (Image/Courtesy of the USC Mark and Mary Stevens Neuroimaging and Informatics Institute)

World’s largest study of a rare genetic disorder offers new insights on schizophrenia

USC researchers are investigating 22q11.2 deletion syndrome, a genetic disorder linked to schizophrenia, in an effort to find a biomarker of the serious mental illness.

Health
child loss USC study
A recent study found that the burden of bereavement after the death of a child is much greater than previously thought, opening the door to new conversations on global inequality. (Illustration/Gabriela Froehlich, Shutterstock)

The death of a child is a devastatingly common experience for many African mothers

By their late 40s, nearly two-thirds of women in sub-Saharan Africa have lost a child, according to a USC study. Researchers are increasingly recognizing bereavement as a public health threat.

Health
Alzheimer's drug USC
In this image taken from tissue of an Alzheimer’s patient, the large pink-and-blue plaque on the lower right contains the abnormal protein amyloid. Also seen are several neurofibrillary tangles (smaller blue areas). Both of these abnormalities disrupt the normal working of the brain. (Image/Simon Fraser, Science Source)

Alzheimer’s study aims to see if drug can block brain plaques linked to disease

Keck School of Medicine of USC is launching a large clinical trial that targets amyloid plaques in the brain. The goal: to see whether a drug can clear or slow this plaque in people who have early Alzheimer’s or who appear clinically normal.